These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Phenylbutazone: back on the French market: reappearance. A NSAID to avoid. Life-threatening toxicity. Prescrire Int; 2009 Apr; 18(100):61. PubMed ID: 19588551 [No Abstract] [Full Text] [Related]
46. [Severe autonomic paroxysm with a fever aura, prolonged fever sensations and a previously unknown neurotonic reaction during Irgapyrin therapy]. BRAUN RN Wien Klin Wochenschr; 1958 Feb; 70(6):103-5. PubMed ID: 13544240 [No Abstract] [Full Text] [Related]
47. [Phenylbutazone, the black 'horse' of the NSAID family?]. de Grauw J; Lipman LJ Tijdschr Diergeneeskd; 2008 Mar; 133(6):232-5. PubMed ID: 18429404 [No Abstract] [Full Text] [Related]
49. [Macroscopic hematuria during treatment with phenylbutazone derivatives. Positive lymphocyte transformation test for these drugs. Two cases in children]. Kesseler A; Aladenise J; Boivin MJ; Greninger G Ann Pediatr (Paris); 1977 Oct; 24(10):703-7. PubMed ID: 16211908 [No Abstract] [Full Text] [Related]
50. [Side effect of butadion]. KHARLASHIN VI Klin Med (Mosk); 1959 Mar; 37(3):93-4. PubMed ID: 13642653 [No Abstract] [Full Text] [Related]
51. [Erythroderma with fatal anuria after irgapyrin]. EBENER H Ther Umsch; 1957 Apr; 14(4):109-12. PubMed ID: 13455587 [No Abstract] [Full Text] [Related]
52. Eczematoid dermatitis following butazolidine injections. PARMAR IS; BEHL PN J Indian Med Assoc; 1957 May; 28(10):435-6. PubMed ID: 13439193 [No Abstract] [Full Text] [Related]
53. [On the toxic action of butazolidin]. Niznikowska-Marks J; Przybylska H; Hanczke-Wojnarowska H Wiad Lek; 1965 Dec; 18(24):1893-5. PubMed ID: 5882284 [No Abstract] [Full Text] [Related]
54. Case histories of two patients with toxic symptoms of drug reaction. McCOMBS AP J Am Med Womens Assoc; 1958 Jul; 13(7):263-7. PubMed ID: 13563229 [No Abstract] [Full Text] [Related]
55. [Observations on the side effects of ACTH & irgapyrin in the treatment of rheumatism]. JASINSKI K Pol Tyg Lek (Wars); 1958 Oct; 13(42):1628-32. PubMed ID: 13623474 [No Abstract] [Full Text] [Related]
56. [Protective effect of ascorbic acid in drug-induced experimental & clinical peptic ulcers, especially by butazolidine]. ARON E Therapie; 1958; 13(2):185-90. PubMed ID: 13556694 [No Abstract] [Full Text] [Related]
57. [Changes induced by phenylbutazone therapy in the histological picture of acute gouty synovitis]. ROBECCHI A; BIRESSI PC; CARTASEGNA F Reumatismo; 1958; 10(Supp 2):89-95. PubMed ID: 13602247 [No Abstract] [Full Text] [Related]
58. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses. Reed SK; Messer NT; Tessman RK; Keegan KG Am J Vet Res; 2006 Mar; 67(3):398-402. PubMed ID: 16506899 [TBL] [Abstract][Full Text] [Related]
59. Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses. Keegan KG; Messer NT; Reed SK; Wilson DA; Kramer J Am J Vet Res; 2008 Feb; 69(2):167-73. PubMed ID: 18241011 [TBL] [Abstract][Full Text] [Related]
60. [Research on the behavior of the glutamic oxalacetic and glutamic pyruvic transaminases in accidental acute phenylbutazone poisoning in children]. BRIGHI W; GOBBI U Minerva Pediatr; 1963 Feb; 15():252-6. PubMed ID: 14015456 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]